ARTICLE | Company News
StemCells neurology, gene/cell therapy news
January 4, 2016 8:00 AM UTC
StemCells will reduce headcount by 17 (about 23%) to 57 to focus resources on developing human neural stem cells (HuCNS-SC) to treat chronic spinal cord injury (SCI). The cuts will come from its U.S.-...